Cryo-Cell International Inc (CCEL)
9.08
+0.34
(+3.89%)
USD |
NYAM |
May 09, 16:00
8.54
-0.54
(-5.95%)
After-Hours: 16:20
Cryo-Cell International Net Income (Quarterly): 0.5562M for Feb. 29, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | 0.5562M |
| November 30, 2023 | -11.19M |
| August 31, 2023 | 0.6806M |
| May 31, 2023 | 0.221M |
| February 28, 2023 | 0.7668M |
| November 30, 2022 | 0.8378M |
| August 31, 2022 | 0.4668M |
| May 31, 2022 | 0.6347M |
| February 28, 2022 | 0.832M |
| November 30, 2021 | -0.6372M |
| August 31, 2021 | 0.8565M |
| May 31, 2021 | 1.171M |
| February 28, 2021 | 0.6936M |
| November 30, 2020 | 1.200M |
| August 31, 2020 | 0.7845M |
| May 31, 2020 | 0.9533M |
| February 29, 2020 | 0.687M |
| November 30, 2019 | 0.845M |
| August 31, 2019 | 1.116M |
| May 31, 2019 | 0.0537M |
| February 28, 2019 | 0.2759M |
| November 30, 2018 | 0.8908M |
| August 31, 2018 | 0.245M |
| May 31, 2018 | 0.5395M |
| February 28, 2018 | -2.530M |
| Date | Value |
|---|---|
| November 30, 2017 | 0.6792M |
| August 31, 2017 | 0.652M |
| May 31, 2017 | 0.4969M |
| February 28, 2017 | 0.4869M |
| November 30, 2016 | 0.8094M |
| August 31, 2016 | -2.644M |
| May 31, 2016 | 0.6371M |
| February 29, 2016 | -0.1229M |
| November 30, 2015 | -0.2194M |
| August 31, 2015 | 7.830M |
| May 31, 2015 | 0.21M |
| February 28, 2015 | 0.2862M |
| November 30, 2014 | -0.2958M |
| August 31, 2014 | 0.2366M |
| May 31, 2014 | 0.2158M |
| February 28, 2014 | 0.3971M |
| November 30, 2013 | -0.1673M |
| August 31, 2013 | 0.1944M |
| May 31, 2013 | -0.2437M |
| February 28, 2013 | 0.244M |
| November 30, 2012 | -0.8544M |
| August 31, 2012 | -0.5471M |
| May 31, 2012 | -3.225M |
| February 29, 2012 | -1.682M |
| November 30, 2011 | -0.124M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-11.19M
Minimum
Nov 2023
1.200M
Maximum
Nov 2020
0.0764M
Average
0.7302M
Median
Net Income (Quarterly) Benchmarks
| American Shared Hospital Services | 0.415M |
| Novo Integrated Sciences Inc | -2.746M |
| Astrana Health Inc | 12.36M |
| P3 Health Partners Inc | -25.46M |
| Biote Corp | 7.734M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 7.852M |
| Total Expenses (Quarterly) | 7.036M |
| EPS Diluted (Quarterly) | 0.0674 |
| Enterprise Value | 80.39M |
| Gross Profit Margin (Quarterly) | 72.49% |
| Profit Margin (Quarterly) | 7.08% |
| Earnings Yield | -12.80% |
| Operating Earnings Yield | 3.70% |
| Normalized Earnings Yield | 1.658 |